A slew of recalled OTC eye drops during the past 2 years has diminished patient trust, but optometrists are equipped to restore it.

DelveInsight's analysis indicates a promising outlook for the dry eye disease market from 2024 to 2034, with positive growth anticipated. This growth trajectory is attributed to the emergence ...

DelveInsight's Dry Eye Disease Market Insights report includes a comprehensive understanding of current treatment practices, ...

The global ophthalmic sprays market, valued at USD 343 million in 2023, is projected to experience exponential growth, reaching a remarkable USD 783.3 million by 2033. This growth is underpinned by a ...

but Levy did not discuss how that might affect pharmaceuticals. Levy said Novo Holdings has a venture vehicle with more than 90 biopharmaceutical assets that will be "a tremendous pipeline" for ...

EyePoint Pharmaceuticals, Inc. announced the granting of non-statutory stock options as inducement awards to four new employees, totaling options to purchase 30,300 shares of common stock.

WATERTOWN, Mass. - EyePoint Pharmaceuticals, Inc. (NASDAQ: NASDAQ:EYPT), a biopharmaceutical company focused on developing treatments for serious retinal diseases ...